A detailed history of Lpl Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lpl Financial LLC holds 3,047,206 shares of BMY stock, worth $175 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,047,206
Previous 2,966,771 2.71%
Holding current value
$175 Million
Previous $123 Million 27.99%
% of portfolio
0.07%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $3.19 Million - $4.16 Million
80,435 Added 2.71%
3,047,206 $158 Million
Q2 2024

Aug 07, 2024

BUY
$40.25 - $52.99 $21.3 Million - $28 Million
529,123 Added 21.71%
2,966,771 $123 Million
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $25.6 Million - $29 Million
533,070 Added 27.99%
2,437,648 $132 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $5.89 Million - $7.03 Million
-121,474 Reduced 6.0%
1,904,578 $97.7 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $4.22 Million - $4.72 Million
72,947 Added 3.73%
2,026,052 $118 Million
Q2 2023

Jul 31, 2023

BUY
$63.71 - $70.74 $8.36 Million - $9.29 Million
131,293 Added 7.21%
1,953,105 $125 Million
Q1 2023

May 10, 2023

BUY
$65.71 - $74.53 $14.7 Million - $16.7 Million
224,031 Added 14.02%
1,821,812 $126 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $4.39 Million - $5.19 Million
-64,039 Reduced 3.85%
1,597,781 $115 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $3,932 - $2.32 Million
-30,252 Reduced 1.79%
1,661,820 $118 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $4.87 Million - $5.36 Million
67,035 Added 4.13%
1,692,072 $130 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $10.8 Million - $13 Million
176,074 Added 12.15%
1,625,037 $119 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $8.99 Million - $10.5 Million
167,661 Added 13.09%
1,448,963 $90.3 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $3.37 Million - $3.95 Million
57,017 Added 4.66%
1,281,302 $75.8 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $3.99 Million - $4.34 Million
64,427 Added 5.55%
1,224,285 $81.8 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $3.14 Million - $3.53 Million
52,858 Added 4.77%
1,159,858 $73.2 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $5.53 Million - $6.27 Million
95,811 Added 9.48%
1,107,000 $68.7 Million
Q3 2020

Nov 09, 2020

BUY
$57.43 - $63.64 $5.75 Million - $6.37 Million
100,138 Added 10.99%
1,011,189 $61 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $7.25 Million - $8.47 Million
132,219 Added 16.98%
911,051 $53.6 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $1 Million - $1.46 Million
21,657 Added 2.86%
778,832 $43.4 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $6.96 Million - $9.08 Million
141,389 Added 22.96%
757,175 $48.6 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $476,971 - $565,517
-11,152 Reduced 1.78%
615,786 $31.2 Million
Q2 2019

Aug 09, 2019

BUY
$44.62 - $49.34 $1.66 Million - $1.83 Million
37,124 Added 6.29%
626,938 $28.4 Million
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $2.83 Million - $3.38 Million
62,821 Added 11.92%
589,814 $28.1 Million
Q4 2018

Feb 07, 2019

SELL
$48.76 - $63.23 $58,609 - $76,002
-1,202 Reduced 0.23%
526,993 $27.4 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $589,649 - $665,079
-10,684 Reduced 1.98%
528,195 $32.8 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $586,905 - $731,512
11,615 Added 2.2%
538,879 $29.8 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $20,672 - $23,798
-345 Reduced 0.07%
527,264 $33.3 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $2.76 Million - $3.01 Million
46,114 Added 9.58%
527,609 $32.3 Million
Q3 2017

Nov 14, 2017

SELL
$55.23 - $63.74 $367,721 - $424,380
-6,658 Reduced 1.36%
481,495 $30.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
488,153
488,153 $27.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.